As of 2026-09-20, the Relative Valuation of Altimmune Inc (ALT) is (9.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.25 USD, the upside of Altimmune Inc based on Relative Valuation is -399.1%.
The range of the Relative Valuation is (8.97) - (11.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.8x | 21.4x |
| Forward P/E multiples | 15.7x - 23.9x | 19.8x |
| Fair Price | (8.97) - (11.23) | (9.72) |
| Upside | -375.8% - -445.5% | -399.1% |
| Date | P/E |
| 2026-09-18 | -6.89 |
| 2026-09-17 | -6.87 |
| 2026-09-16 | -6.87 |
| 2026-09-15 | -6.85 |
| 2026-09-14 | -6.99 |
| 2026-09-11 | -6.93 |
| 2026-09-10 | -6.97 |
| 2026-09-09 | -7.10 |
| 2026-09-08 | -7.12 |
| 2026-09-04 | -7.25 |
| 2026-09-03 | -6.85 |
| 2026-09-02 | -6.95 |
| 2026-09-01 | -6.55 |
| 2026-08-31 | -6.59 |
| 2026-08-28 | -6.59 |
| 2026-08-27 | -6.87 |
| 2026-08-26 | -6.68 |
| 2026-08-25 | -6.78 |
| 2026-08-24 | -6.59 |
| 2026-08-21 | -6.59 |
| 2026-08-20 | -6.25 |
| 2026-08-19 | -6.61 |
| 2026-08-18 | -6.29 |
| 2026-08-17 | -6.36 |
| 2026-08-14 | -6.23 |
| 2026-08-13 | -6.10 |
| 2026-08-12 | -6.21 |
| 2026-08-11 | -6.36 |
| 2026-08-10 | -6.46 |
| 2026-08-07 | -6.53 |
| 2026-08-06 | -6.38 |
| 2026-08-05 | -6.42 |
| 2026-08-04 | -6.51 |
| 2026-08-03 | -6.36 |
| 2026-07-31 | -6.02 |
| 2026-07-30 | -6.32 |
| 2026-07-29 | -6.19 |
| 2026-07-28 | -6.34 |
| 2026-07-27 | -6.27 |
| 2026-07-24 | -5.87 |
| 2026-07-23 | -6.02 |
| 2026-07-22 | -5.96 |
| 2026-07-21 | -5.98 |
| 2026-07-20 | -5.96 |
| 2026-07-17 | -6.08 |
| 2026-07-16 | -6.04 |
| 2026-07-15 | -6.32 |
| 2026-07-14 | -6.21 |
| 2026-07-13 | -6.34 |
| 2026-07-10 | -6.46 |